Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$611,429
-$551,554 QoQ
Shares Held
4,988
-54.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#200
of 341 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $326,523,942 across 90 Biotechnology names. PTGX ranks #67 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,685 | $47,529,610 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,896 | $27,370,911 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
109,096 | $20,431,498 | |
| 4 | EXEL |
Exelixis, Inc.
|
375,316 | $20,420,943 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
190,305 | $14,895,171 | |
| 6 | INCY |
Incyte Corp
|
102,834 | $11,657,262 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,541 | $10,096,847 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
241,565 | $9,348,565 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $611,429 | 4,988 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,162,983 | 11,034 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $594,216 | 8,945 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,314,153 | 23,777 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $938,667 | 19,410 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $811,063 | 21,012 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $992,790 | 22,062 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $764,448 | 22,062 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||